Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old
Clinical trial NCT01161160 · COMPLETED
Trial details
- NCT number
- NCT01161160
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2010-08-23
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.